Skip to content

MAZE MAZE Change in Lease Liabilities

Change in Lease Liabilities at other companies

Septerna, Inc. logo
Septerna, Inc.SEPN
-$535K-18.9%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$313K-1.3%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$205K+112%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
-$211K-14.7%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-$123K+35.3%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$802K+20.9%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B+201%
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's change in lease liabilities?
MAZE (MAZE) reported change in lease liabilities of -$915K in Q1 2026.
How has MAZE's change in lease liabilities changed year-over-year?
MAZE's change in lease liabilities decreased by 13.7% year-over-year, from -$805K to -$915K.
What does change in lease liabilities mean?
Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.